Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QVM149 vs QMF149 in Japanese patients with asthma
jRCT2080223228Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of indacaterol acetate + glycopyrronium bromide + mometasone furoate in asthma (3 arms), sponsored by Novartis. Started Jun 2016; status: completed.
02
Drugs
indacaterol acetate + glycopyrronium bromide + mometasone furoate
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080223228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223228.